Global Flu (Influenza) Vaccine Market Research Report 2025(Status and Outlook)

March 2025 | 224 pages | ID: G086B14CB4AFEN
Bosson Research

Abstracts

Report Overview

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

This report provides a deep insight into the global Flu (Influenza) Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Flu (Influenza) Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Flu (Influenza) Vaccine market in any manner.

Global Flu (Influenza) Vaccine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Hualan Bio

CCBIO

Aleph Biomedical

SANOFI

Adimmune

ZYAK

SINOVAC

Changsheng Biological

SIOBP

GSK

Aimei Hissen

Tianyuan Bio-pharma(Novartis)

Simcere Vaxtec

Market Segmentation (by Type)

Split Influenza Vaccine

Pandemic Influenza Vaccine

Subunit Influenza Vaccine

Quadrivalent Influenza Vaccine

Market Segmentation (by Application)

For Children (6 months to 3 years)

For Adults and Children over 3 years

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Flu (Influenza) Vaccine Market
• Overview of the regional outlook of the Flu (Influenza) Vaccine Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Flu (Influenza) Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Flu (Influenza) Vaccine
1.2 Key Market Segments
1.2.1 Flu (Influenza) Vaccine Segment by Type
1.2.2 Flu (Influenza) Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Flu (Influenza) Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Flu (Influenza) Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Flu (Influenza) Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Flu (Influenza) Vaccine Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Flu (Influenza) Vaccine Product Life Cycle
3.3 Global Flu (Influenza) Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Flu (Influenza) Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Flu (Influenza) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Flu (Influenza) Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Flu (Influenza) Vaccine Manufacturing Sites, Area Served, Product Type
3.8 Flu (Influenza) Vaccine Market Competitive Situation and Trends
3.8.1 Flu (Influenza) Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Flu (Influenza) Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Flu (Influenza) Vaccine Industry Chain Analysis
4.1 Flu (Influenza) Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Flu (Influenza) Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Flu (Influenza) Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Flu (Influenza) Vaccine Market
5.7 ESG Ratings of Leading Companies
6 Global Flu (Influenza) Vaccine Market by Region
6.1 Global Flu (Influenza) Vaccine Market Size by Region
6.1.1 Global Flu (Influenza) Vaccine Market Size by Region
6.1.2 Global Flu (Influenza) Vaccine Market Size Market Share by Region
6.2 Global Flu (Influenza) Vaccine Sales by Region
6.2.1 Global Flu (Influenza) Vaccine Sales by Region
6.2.2 Global Flu (Influenza) Vaccine Sales Market Share by Region
7 North America Market Overview
7.1 North America Flu (Influenza) Vaccine Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Flu (Influenza) Vaccine Market Size by Type
7.3 North America Flu (Influenza) Vaccine Market Size by Application
8 Europe Market Overview
8.1 Europe Flu (Influenza) Vaccine Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Flu (Influenza) Vaccine Market Size by Type
8.3 Europe Flu (Influenza) Vaccine Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Flu (Influenza) Vaccine Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Flu (Influenza) Vaccine Market Size by Type
9.3 Asia-Pacific Flu (Influenza) Vaccine Market Size by Application
10 South America Market Overview
10.1 South America Flu (Influenza) Vaccine Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Flu (Influenza) Vaccine Market Size by Type
10.3 South America Flu (Influenza) Vaccine Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Flu (Influenza) Vaccine Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Flu (Influenza) Vaccine Market Size by Type
11.3 Middle East and Africa Flu (Influenza) Vaccine Market Size by Application
12 Flu (Influenza) Vaccine Market Production by Region
12.1 Global Production of Flu (Influenza) Vaccine by Region(2020-2025)
12.2 Global Flu (Influenza) Vaccine Revenue Market Share by Region (2020-2025)
12.3 Global Flu (Influenza) Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Flu (Influenza) Vaccine Production
12.4.1 North America Flu (Influenza) Vaccine Production Growth Rate (2020-2025)
12.4.2 North America Flu (Influenza) Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Flu (Influenza) Vaccine Production
12.5.1 Europe Flu (Influenza) Vaccine Production Growth Rate (2020-2025)
12.5.2 Europe Flu (Influenza) Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Flu (Influenza) Vaccine Production (2020-2025)
12.6.1 Japan Flu (Influenza) Vaccine Production Growth Rate (2020-2025)
12.6.2 Japan Flu (Influenza) Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Flu (Influenza) Vaccine Production (2020-2025)
12.7.1 China Flu (Influenza) Vaccine Production Growth Rate (2020-2025)
12.7.2 China Flu (Influenza) Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
13 Flu (Influenza) Vaccine Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Flu (Influenza) Vaccine Sales Market Share by Type (2020-2033)
13.3 Global Flu (Influenza) Vaccine Market Size Market Share by Type (2020-2033)
13.4 Global Flu (Influenza) Vaccine Price by Type (2020-2033)
14 Flu (Influenza) Vaccine Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Flu (Influenza) Vaccine Market Sales by Application (2020-2033)
14.3 Global Flu (Influenza) Vaccine Market Size (M USD) by Application (2020-2033)
14.4 Global Flu (Influenza) Vaccine Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Hualan Bio
15.1.1 Hualan Bio Basic Information
15.1.2 Hualan Bio Flu (Influenza) Vaccine Product Overview
15.1.3 Hualan Bio Flu (Influenza) Vaccine Product Market Performance
15.1.4 Hualan Bio Business Overview
15.1.5 Hualan Bio SWOT Analysis
15.1.6 Hualan Bio Recent Developments
15.2 CCBIO
15.2.1 CCBIO Basic Information
15.2.2 CCBIO Flu (Influenza) Vaccine Product Overview
15.2.3 CCBIO Flu (Influenza) Vaccine Product Market Performance
15.2.4 CCBIO Business Overview
15.2.5 CCBIO SWOT Analysis
15.2.6 CCBIO Recent Developments
15.3 Aleph Biomedical
15.3.1 Aleph Biomedical Basic Information
15.3.2 Aleph Biomedical Flu (Influenza) Vaccine Product Overview
15.3.3 Aleph Biomedical Flu (Influenza) Vaccine Product Market Performance
15.3.4 Aleph Biomedical Business Overview
15.3.5 Aleph Biomedical SWOT Analysis
15.3.6 Aleph Biomedical Recent Developments
15.4 SANOFI
15.4.1 SANOFI Basic Information
15.4.2 SANOFI Flu (Influenza) Vaccine Product Overview
15.4.3 SANOFI Flu (Influenza) Vaccine Product Market Performance
15.4.4 SANOFI Business Overview
15.4.5 SANOFI Recent Developments
15.5 Adimmune
15.5.1 Adimmune Basic Information
15.5.2 Adimmune Flu (Influenza) Vaccine Product Overview
15.5.3 Adimmune Flu (Influenza) Vaccine Product Market Performance
15.5.4 Adimmune Business Overview
15.5.5 Adimmune Recent Developments
15.6 ZYAK
15.6.1 ZYAK Basic Information
15.6.2 ZYAK Flu (Influenza) Vaccine Product Overview
15.6.3 ZYAK Flu (Influenza) Vaccine Product Market Performance
15.6.4 ZYAK Business Overview
15.6.5 ZYAK Recent Developments
15.7 SINOVAC
15.7.1 SINOVAC Basic Information
15.7.2 SINOVAC Flu (Influenza) Vaccine Product Overview
15.7.3 SINOVAC Flu (Influenza) Vaccine Product Market Performance
15.7.4 SINOVAC Business Overview
15.7.5 SINOVAC Recent Developments
15.8 Changsheng Biological
15.8.1 Changsheng Biological Basic Information
15.8.2 Changsheng Biological Flu (Influenza) Vaccine Product Overview
15.8.3 Changsheng Biological Flu (Influenza) Vaccine Product Market Performance
15.8.4 Changsheng Biological Business Overview
15.8.5 Changsheng Biological Recent Developments
15.9 SIOBP
15.9.1 SIOBP Basic Information
15.9.2 SIOBP Flu (Influenza) Vaccine Product Overview
15.9.3 SIOBP Flu (Influenza) Vaccine Product Market Performance
15.9.4 SIOBP Business Overview
15.9.5 SIOBP Recent Developments
15.10 GSK
15.10.1 GSK Basic Information
15.10.2 GSK Flu (Influenza) Vaccine Product Overview
15.10.3 GSK Flu (Influenza) Vaccine Product Market Performance
15.10.4 GSK Business Overview
15.10.5 GSK Recent Developments
15.11 Aimei Hissen
15.11.1 Aimei Hissen Basic Information
15.11.2 Aimei Hissen Flu (Influenza) Vaccine Product Overview
15.11.3 Aimei Hissen Flu (Influenza) Vaccine Product Market Performance
15.11.4 Aimei Hissen Business Overview
15.11.5 Aimei Hissen Recent Developments
15.12 Tianyuan Bio-pharma(Novartis)
15.12.1 Tianyuan Bio-pharma(Novartis) Basic Information
15.12.2 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product Overview
15.12.3 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product Market Performance
15.12.4 Tianyuan Bio-pharma(Novartis) Business Overview
15.12.5 Tianyuan Bio-pharma(Novartis) Recent Developments
15.13 Simcere Vaxtec
15.13.1 Simcere Vaxtec Basic Information
15.13.2 Simcere Vaxtec Flu (Influenza) Vaccine Product Overview
15.13.3 Simcere Vaxtec Flu (Influenza) Vaccine Product Market Performance
15.13.4 Simcere Vaxtec Business Overview
15.13.5 Simcere Vaxtec Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Flu (Influenza) Vaccine Market Size by Type (M USD)
Table 4. Global Flu (Influenza) Vaccine Market Size by Application (M USD)
Table 5. Flu (Influenza) Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Flu (Influenza) Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Flu (Influenza) Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Flu (Influenza) Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Flu (Influenza) Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flu (Influenza) Vaccine as of 2024)
Table 11. Global Market Flu (Influenza) Vaccine Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Flu (Influenza) Vaccine Manufacturing Sites and Area Served
Table 13. Manufacturers Flu (Influenza) Vaccine Product Type
Table 14. Global Flu (Influenza) Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Flu (Influenza) Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Flu (Influenza) Vaccine Market Size Comparison by Region (M USD)
Table 26. Global Flu (Influenza) Vaccine Market Size by Region (2020-2033) & (M USD)
Table 27. Global Flu (Influenza) Vaccine Market Size Market Share by Region (2020-2033)
Table 28. Global Flu (Influenza) Vaccine Sales by Region (2020-2033) & (K MT)
Table 29. Global Flu (Influenza) Vaccine Sales Market Share by Region (2020-2033)
Table 30. North America Flu (Influenza) Vaccine Market Size by Country (2020-2033) & (M USD)
Table 31. North America Flu (Influenza) Vaccine Sales by Country (2020-2033) & (K MT)
Table 32. North America Flu (Influenza) Vaccine Sales by Type (K MT)
Table 33. North America Flu (Influenza) Vaccine Market Size by Type (M USD)
Table 34. North America Flu (Influenza) Vaccine Sales (K MT) by Type (2020-2033)
Table 35. North America Flu (Influenza) Vaccine Market Size (M USD) by Type (2020-2033)
Table 36. North America Flu (Influenza) Vaccine Sales by Application (K MT)
Table 37. North America Flu (Influenza) Vaccine Market Size by Application (M USD)
Table 38. North America Flu (Influenza) Vaccine Sales (K MT) by Application (2020-2033)
Table 39. North America Flu (Influenza) Vaccine Market Size (M USD) by Application (2020-2033)
Table 40. Europe Flu (Influenza) Vaccine Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Flu (Influenza) Vaccine Sales by Country (2020-2033) & (K MT)
Table 42. Europe Flu (Influenza) Vaccine Sales by Type (K MT)
Table 43. Europe Flu (Influenza) Vaccine Market Size by Type (M USD)
Table 44. Europe Flu (Influenza) Vaccine Sales (K MT) by Type (2020-2033)
Table 45. Europe Flu (Influenza) Vaccine Market Size (M USD) by Type (2020-2033)
Table 46. Europe Flu (Influenza) Vaccine Sales by Application (K MT)
Table 47. Europe Flu (Influenza) Vaccine Market Size by Application (M USD)
Table 48. Europe Flu (Influenza) Vaccine Sales (K MT) by Application (2020-2033)
Table 49. Europe Flu (Influenza) Vaccine Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Flu (Influenza) Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Flu (Influenza) Vaccine Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Flu (Influenza) Vaccine Sales by Type (K MT)
Table 53. Asia-Pacific Flu (Influenza) Vaccine Market Size by Type (M USD)
Table 54. Asia-Pacific Flu (Influenza) Vaccine Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Flu (Influenza) Vaccine Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Flu (Influenza) Vaccine Sales by Application (K MT)
Table 57. Asia-Pacific Flu (Influenza) Vaccine Market Size by Application (M USD)
Table 58. Asia-Pacific Flu (Influenza) Vaccine Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Flu (Influenza) Vaccine Market Size (M USD) by Application (2020-2025)
Table 60. South America Flu (Influenza) Vaccine Market Size by Country (2020-2033) & (M USD)
Table 61. South America Flu (Influenza) Vaccine Sales by Country (2020-2033) & (K MT)
Table 62. South America Flu (Influenza) Vaccine Sales by Type (K MT)
Table 63. South America Flu (Influenza) Vaccine Market Size by Type (M USD)
Table 64. South America Flu (Influenza) Vaccine Sales (K MT) by Type (2020-2033)
Table 65. South America Flu (Influenza) Vaccine Market Size (M USD) by Type (2020-2033)
Table 66. South America Flu (Influenza) Vaccine Sales by Application (K MT)
Table 67. South America Flu (Influenza) Vaccine Market Size by Application (M USD)
Table 68. South America Flu (Influenza) Vaccine Sales (K MT) by Application (2020-2033)
Table 69. South America Flu (Influenza) Vaccine Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Flu (Influenza) Vaccine Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Flu (Influenza) Vaccine Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Flu (Influenza) Vaccine Sales by Type (K MT)
Table 73. Middle East and Africa Flu (Influenza) Vaccine Market Size by Type (M USD)
Table 74. Middle East and Africa Flu (Influenza) Vaccine Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Flu (Influenza) Vaccine Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Flu (Influenza) Vaccine Sales by Application (K MT)
Table 77. Middle East and Africa Flu (Influenza) Vaccine Market Size by Application (M USD)
Table 78. Middle East and Africa Flu (Influenza) Vaccine Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Flu (Influenza) Vaccine Market Size (M USD) by Application (2020-2033)
Table 80. Global Flu (Influenza) Vaccine Production (K MT) by Region(2020-2025)
Table 81. Global Flu (Influenza) Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Flu (Influenza) Vaccine Revenue Market Share by Region (2020-2025)
Table 83. Global Flu (Influenza) Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Flu (Influenza) Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Flu (Influenza) Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Flu (Influenza) Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Flu (Influenza) Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Flu (Influenza) Vaccine Sales by Type (K MT)
Table 89. Global Flu (Influenza) Vaccine Market Size by Type (M USD)
Table 90. Global Flu (Influenza) Vaccine Sales (K MT) by Type (2020-2033)
Table 91. Global Flu (Influenza) Vaccine Sales Market Share by Type (2020-2033)
Table 92. Global Flu (Influenza) Vaccine Market Size (M USD) by Type (2020-2033)
Table 93. Global Flu (Influenza) Vaccine Market Size Share by Type (2020-2033)
Table 94. Global Flu (Influenza) Vaccine Sales (K MT) by Application
Table 95. Global Flu (Influenza) Vaccine Market Size by Application(M USD)
Table 96. Global Flu (Influenza) Vaccine Sales by Application (2020-2033) & (K MT)
Table 97. Global Flu (Influenza) Vaccine Sales Market Share by Application (2020-2033)
Table 98. Global Flu (Influenza) Vaccine Market Size by Application (2020-2033) & (M USD)
Table 99. Global Flu (Influenza) Vaccine Market Share by Application (2020-2033)
Table 100. Global Flu (Influenza) Vaccine Sales Growth Rate by Application (2020-2033)
Table 101. Hualan Bio Basic Information
Table 102. Hualan Bio Flu (Influenza) Vaccine Product Overview
Table 103. Hualan Bio Flu (Influenza) Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Hualan Bio Business Overview
Table 105. Hualan Bio SWOT Analysis
Table 106. Hualan Bio Recent Developments
Table 107. CCBIO Basic Information
Table 108. CCBIO Flu (Influenza) Vaccine Product Overview
Table 109. CCBIO Flu (Influenza) Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. CCBIO Business Overview
Table 111. CCBIO SWOT Analysis
Table 112. CCBIO Recent Developments
Table 113. Aleph Biomedical Basic Information
Table 114. Aleph Biomedical Flu (Influenza) Vaccine Product Overview
Table 115. Aleph Biomedical Flu (Influenza) Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Aleph Biomedical Business Overview
Table 117. Aleph Biomedical SWOT Analysis
Table 118. Aleph Biomedical Recent Developments
Table 119. SANOFI Basic Information
Table 120. SANOFI Flu (Influenza) Vaccine Product Overview
Table 121. SANOFI Flu (Influenza) Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. SANOFI Business Overview
Table 123. SANOFI Recent Developments
Table 124. Adimmune Basic Information
Table 125. Adimmune Flu (Influenza) Vaccine Product Overview
Table 126. Adimmune Flu (Influenza) Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Adimmune Business Overview
Table 128. Adimmune Recent Developments
Table 129. ZYAK Basic Information
Table 130. ZYAK Flu (Influenza) Vaccine Product Overview
Table 131. ZYAK Flu (Influenza) Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. ZYAK Business Overview
Table 133. ZYAK Recent Developments
Table 134. SINOVAC Basic Information
Table 135. SINOVAC Flu (Influenza) Vaccine Product Overview
Table 136. SINOVAC Flu (Influenza) Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. SINOVAC Business Overview
Table 138. SINOVAC Recent Developments
Table 139. Changsheng Biological Basic Information
Table 140. Changsheng Biological Flu (Influenza) Vaccine Product Overview
Table 141. Changsheng Biological Flu (Influenza) Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Changsheng Biological Business Overview
Table 143. Changsheng Biological Recent Developments
Table 144. SIOBP Basic Information
Table 145. SIOBP Flu (Influenza) Vaccine Product Overview
Table 146. SIOBP Flu (Influenza) Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. SIOBP Business Overview
Table 148. SIOBP Recent Developments
Table 149. GSK Basic Information
Table 150. GSK Flu (Influenza) Vaccine Product Overview
Table 151. GSK Flu (Influenza) Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. GSK Business Overview
Table 153. GSK Recent Developments
Table 154. Aimei Hissen Basic Information
Table 155. Aimei Hissen Flu (Influenza) Vaccine Product Overview
Table 156. Aimei Hissen Flu (Influenza) Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Aimei Hissen Business Overview
Table 158. Aimei Hissen Recent Developments
Table 159. Tianyuan Bio-pharma(Novartis) Basic Information
Table 160. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product Overview
Table 161. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Tianyuan Bio-pharma(Novartis) Business Overview
Table 163. Tianyuan Bio-pharma(Novartis) Recent Developments
Table 164. Simcere Vaxtec Basic Information
Table 165. Simcere Vaxtec Flu (Influenza) Vaccine Product Overview
Table 166. Simcere Vaxtec Flu (Influenza) Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Simcere Vaxtec Business Overview
Table 168. Simcere Vaxtec Recent Developments
List of Figures
Figure 1. Product Picture of Flu (Influenza) Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Flu (Influenza) Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Flu (Influenza) Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Flu (Influenza) Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Flu (Influenza) Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Flu (Influenza) Vaccine Product Life Cycle
Figure 13. Flu (Influenza) Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Flu (Influenza) Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Flu (Influenza) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Flu (Influenza) Vaccine Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Flu (Influenza) Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Flu (Influenza) Vaccine
Figure 19. Global Flu (Influenza) Vaccine Market PEST Analysis
Figure 20. Global Flu (Influenza) Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Flu (Influenza) Vaccine Market Size by Region
Figure 27. Global Flu (Influenza) Vaccine Market Size Market Share by Region (2020-2033)
Figure 28. Global Flu (Influenza) Vaccine Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Flu (Influenza) Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Flu (Influenza) Vaccine Market Size (M USD) by Country
Figure 33. USA Flu (Influenza) Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Flu (Influenza) Vaccine Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Flu (Influenza) Vaccine Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Flu (Influenza) Vaccine Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Flu (Influenza) Vaccine Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Flu (Influenza) Vaccine Market Size (M USD)by Type
Figure 40. North America Flu (Influenza) Vaccine Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Flu (Influenza) Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Flu (Influenza) Vaccine Market Size (M USD) by Country
Figure 45. Germany Flu (Influenza) Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Flu (Influenza) Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Flu (Influenza) Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Flu (Influenza) Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Flu (Influenza) Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Flu (Influenza) Vaccine Market Size (M USD) by Type
Figure 56. Europe Flu (Influenza) Vaccine Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Flu (Influenza) Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Flu (Influenza) Vaccine Market Size (M USD) by Country
Figure 61. China Flu (Influenza) Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Flu (Influenza) Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Flu (Influenza) Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Flu (Influenza) Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Flu (Influenza) Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Flu (Influenza) Vaccine Market Size (M USD) by Type
Figure 72. Asia-Pacific Flu (Influenza) Vaccine Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Flu (Influenza) Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Flu (Influenza) Vaccine Market Size (M USD) by Country
Figure 77. Brazil Flu (Influenza) Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Flu (Influenza) Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Flu (Influenza) Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Flu (Influenza) Vaccine Market Size (M USD) by Type
Figure 84. South America Flu (Influenza) Vaccine Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Flu (Influenza) Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Flu (Influenza) Vaccine Market Size (M USD) by Country
Figure 89. Saudi Arabia Flu (Influenza) Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Flu (Influenza) Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Flu (Influenza) Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Flu (Influenza) Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Flu (Influenza) Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Flu (Influenza) Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Flu (Influenza) Vaccine Market Size (M USD) by Type
Figure 100. Middle East and Africa Flu (Influenza) Vaccine Market Size (M USD) by Application
Figure 101. Global Flu (Influenza) Vaccine Production Market Share by Region (2020-2025)
Figure 102. North America Flu (Influenza) Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Flu (Influenza) Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Flu (Influenza) Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. China Flu (Influenza) Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Flu (Influenza) Vaccine Market Size by Type (M USD)
Figure 108. Sales Market Share of Flu (Influenza) Vaccine by Type (2020-2033)
Figure 109. Sales Market Share of Flu (Influenza) Vaccine by Type in 2024
Figure 110. Market Size Share of Flu (Influenza) Vaccine by Type (2020-2033)
Figure 111. Market Size Share of Flu (Influenza) Vaccine by Type in 2024
Figure 112. Global Flu (Influenza) Vaccine Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Flu (Influenza) Vaccine Market Size by Application(M USD)
Figure 115. Global Flu (Influenza) Vaccine Market Share by Application
Figure 116. Global Flu (Influenza) Vaccine Sales Market Share by Application (2020-2033)
Figure 117. Global Flu (Influenza) Vaccine Sales Market Share by Application in 2024
Figure 118. Global Flu (Influenza) Vaccine Market Share by Application (2020-2033)
Figure 119. Global Flu (Influenza) Vaccine Market Share by Application in 2024
Figure 120. Global Flu (Influenza) Vaccine Sales Growth Rate by Application (2020-2033)